St. David’s becomes first Central Texas hospital to offer new liver cancer therapy
Dr. McKenzie explains histotripsy, a new noninvasive liver tumor treatment, its benefits for cancer patients, and its market significance amid rising cases.
Shaun P. McKenzie, M.D., FACS, Texas Oncology Surgical Specialists–Round Rock and South Austin, shared information on a new, noninvasive treatment for liver tumors called histotripsy. Dr. McKenzie discussed how histotripsy works, why it matters to cancer patients, and the significance in the marketplace, particularly in light of the significant rise in liver cancer incidence in the United States.
Read the full story in Community Impact.